期刊
AMERICAN JOURNAL OF INFECTION CONTROL
卷 39, 期 10, 页码 E67-E72出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ajic.2011.04.329
关键词
IGRAs; specificity; annual chest X-ray examination; latent tuberculosis infection; active tuberculosis
Background: Currently, an annual chest X-ray examination (CXR) for detection of active tuberculosis (TB) in employees aged >= 40 years is recommended in the guidelines of the Japan Industrial Safety and Health Law. Interferon-gamma release assays are new alternatives to the tuberculin skin test for detecting Mycobacterium tuberculosis infection, with higher specificity than the tuberculin skin test and without cross-reactivity with the Bacille Calmette-Guerin vaccine. This study aimed to assess the cost-effectiveness of employee TB screening using QuantiFERON-TB Gold In-Tube (QFT) versus CXR. Methods: Markov models were constructed. The target population was a hypothetical cohort of immunocompetent 40-year-old individuals, using a societal perspective and a lifetime horizon. All costs and clinical benefits were discounted at a fixed annual rate of 3%. Results: In a base-case analysis, the QFT strategy was the most cost-effective ($US 262.84; 22.87049 quality-adjusted life-years [QALYs]) compared with no screening ($448.38; 22.85452 QALYs) and CXR ($543.50; 22.85453 QALYs) [year 2009 values]. Conclusion: The QFT strategy is currently robust for screening Bacille Calmette-Guerin-vaccinated employees in Japan. There appears to be little role for CXR. These findings may be applicable to other countries in terms of choosing optimal TB screening for employees.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据